RecruitingEarly Phase 1NCT04499365

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

68Ga-DOTA/NOTA-FAPI-04 PET/CT in Patients With Various Types of Cancer

Sponsor

First Affiliated Hospital of Fujian Medical University

Enrollment

500 participants

Start Date

Aug 15, 2020

Study Type

INTERVENTIONAL

Conditions

Metastasis Tumor Positron Emission Tomography

Summary

To evaluate the potential usefulness of 68Ga-DOTA/NOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 68Ga-DOTA/NOTA-FAPI-04 and PET/CT scan for people with metastasis, positron emission tomography, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.